|
Prior to the merger with IDM Dr. McKearn served as a director of Epimmune. Since March 2005 he has served as Chief Executive Officer and President of Kalypsys Inc. a privately held biotechnology company where he also served as President and Chief Scientific Officer from August 2004 to March 2005 and Chief Scientific Officer from July 2003 to August 2004. In addition Dr. McKearn has been a member of the board of directors of Kalypsys since July 2003. Prior to that he was with Pharmacia Corporation formerly G.D. Searle and Co. a pharmaceutical company since 1987. From August 2000 until June 2003 he served as Senior Vice President Pharmacia Discovery Research responsible for research activities in cardiovascular diseases arthritis and oncology. Prior to that he served as Vice President Searle Discovery Research from 1999 to 2000 Executive Director of Oncology from 1995 to 1999 and directed all arthritis inflammation and oncology research from 1987 to 1995. Dr. McKearn was a Senior Scientist at E.I. DuPont de Nemours and Company a pharmaceutical company from 1985 to 1987 and a member of the Basel Institute for Immunology from 1982 to 1985.
| 